CV Sciences Inc
For the period ended Mar 31, 2024. Filed May 15, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 15, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| Exhibit Number | Exhibit Description | Form | File No. | Exhibit | Filing Date | Filed Herewith |
|---|---|---|---|---|---|---|
| 2.1 · Membership Interest Purchase Agreement, dated May 8, 2024, by and among the Company, Elevated Softgels LLC, Clayton J. Montgomery, Chris Fagan, Andrew Kester, and Timothy McGreer · X | ||||||
| 3.1 | Certificate of Incorporation of CannaVEST Corp., as filed on July 26, 2013. | 10-Q | 000-54677 | 3.1 | August 13, 2013 | |
| 3.2 | Bylaws of CannaVEST Corp., dated as of June 26, 2013. | 10-Q | 000-54677 | 3.2 | August 13, 2013 | |
| 3.3 | Certificate of Amendment to Certificate of Incorporation of CannaVest Corp., as filed on January 4, 2016. | 10-K | 000-54677 | 3.3 | April 14, 2016 | |
| 3.4 | Certificate of Incorporation of the Company, as amended. | 10-Q | 000-54677 | 3.4 | May 16, 2016 | |
| 3.5 | Amendment to the Bylaws of the Company, as amended. | 8-K | 000-54677 | 3.1 | March 22, 2017 | |
| 3.6 | Bylaws of the Company, as amended. | 10-Q | 000-54677 | 3.6 | May 9, 2017 | |
| 3.7 | Amendment to the Bylaws of the Company, as amended | 8-K | 000-54677 | 3.1 | June 14, 2021 | |
| 3.8 | Certificate of Designation of Preference, Rights and Limitations of Convertible Preferred Stock. | 8-K | 000-54677 | 3.1 | April 1, 2022 | |
| 3.9 | Certificate of Amendment to Certificate of Incorporation of CV Sciences, Inc., as filed on June 6, 2022 | 10-Q | 000-54677 | 3.9 | August 15, 2022 | |
| 4.1 | CannaVEST Corp. Specimen Stock Certificate | 8-K | 000-54677 | 4.1 | July 31, 2013 | |
| 4.2 | Form of Warrant, dated March 30, 2022 | 8-K | 000-54677 | 4.1 | April 1, 2022 | |
| 4.3 | Form of Placement Agent Warrant, dated March 30, 2022 | 8-K | 000-54677 | 4.2 | April 1, 2022 | |
| 31.1* | Certification of the Chief Executive Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002. | X | ||||
| 31.2* | Certification of the Chief Financial Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002. | X | ||||
| 32.1* | Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | X | ||||
| 32.2* | Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | X | ||||
| 101 INS* | Inline XBRL Instance Document** | X | ||||
| 101 SCH* | Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents** | X | ||||
| 104** | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101 attachments) | X | ||||
- Filed herewith.
** The XBRL related information in Exhibit 101 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability of that section and shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.